Hiroaki Araki

5.2k total citations · 1 hit paper
267 papers, 4.2k citations indexed

About

Hiroaki Araki is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Pharmacology. According to data from OpenAlex, Hiroaki Araki has authored 267 papers receiving a total of 4.2k indexed citations (citations by other indexed papers that have themselves been cited), including 118 papers in Cellular and Molecular Neuroscience, 77 papers in Molecular Biology and 43 papers in Pharmacology. Recurrent topics in Hiroaki Araki's work include Neuroscience and Neuropharmacology Research (76 papers), Neurotransmitter Receptor Influence on Behavior (61 papers) and Pharmacy and Medical Practices (41 papers). Hiroaki Araki is often cited by papers focused on Neuroscience and Neuropharmacology Research (76 papers), Neurotransmitter Receptor Influence on Behavior (61 papers) and Pharmacy and Medical Practices (41 papers). Hiroaki Araki collaborates with scholars based in Japan, United States and New Zealand. Hiroaki Araki's co-authors include Katsuya Suemaru, Yutaka Gomita, Yasuko Karasawa, Yasuo Uchiyama, Noboru Sato, Tohru Nitatori, Eiki Kominami, Kazuo Shibanai, Satoshi Waguri and Akihiro Tanaka and has published in prestigious journals such as Journal of Neuroscience, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Hiroaki Araki

257 papers receiving 4.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Delayed neuronal death in the CA1 pyramidal cell layer of the gerbil hippocampus following transient ischemia is apoptosis

1995 726 citations Hiroaki Araki et al. profile →

Peers

Countries citing papers authored by Hiroaki Araki

Since Specialization

Citations

This map shows the geographic impact of Hiroaki Araki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hiroaki Araki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hiroaki Araki more than expected).

Fields of papers citing papers by Hiroaki Araki

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hiroaki Araki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hiroaki Araki. The network helps show where Hiroaki Araki may publish in the future.

Co-authorship network of co-authors of Hiroaki Araki

This figure shows the co-authorship network connecting the top 25 collaborators of Hiroaki Araki. A scholar is included among the top collaborators of Hiroaki Araki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hiroaki Araki. Hiroaki Araki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Screening of furanocoumarin derivatives as cytochrome P450 3A4 inhibitors in citrus 2017 ·Journal of Clinical Pharmacy and Therapeutics ·Megumi Masuda, (unknown), Masaaki Tanaka, Akihiro Tanaka, Hiroaki Araki	10
2	Evaluation of ^\|^ldquo;Patient Medication Notebook^\|^rdquo; as a Tool for Sharing Patient Information among Psychiatry Outpatient Team Members 2011 ·Iryo Yakugaku (Japanese Journal of Pharmaceutical Health Care and Sciences) ·(unknown), (unknown), Katsuya Suemaru, (unknown), (unknown), Fumie Horiuchi, (unknown), (unknown), (unknown), (unknown), (unknown), Shuichi Ueno, Hiroaki Araki	1
3	Investigation of Drugs Brought to Hospital by Inpatients with Renal Dysfunction and Ensuring Their Proper Use 2009 ·Iryo Yakugaku (Japanese Journal of Pharmaceutical Health Care and Sciences) ·(unknown), Akihiro Tanaka, (unknown), (unknown), Katsuya Suemaru, Hiroaki Araki	1
4	Training in Drug Counseling using Role-play and Video Recordings-Repeat Training using Case-based Learning (CBL) Procedures and its Evaluation- 2007 ·Iryo Yakugaku (Japanese Journal of Pharmaceutical Health Care and Sciences) ·(unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Takumi Yamaguchi, Katsuya Suemaru, Hiroaki Araki	6
5	Interaction of Drugs with Dietary Fiber-Adsorption of Drugs onto Dietary Fiber in in vitro Study- 2006 ·Iryo Yakugaku (Japanese Journal of Pharmaceutical Health Care and Sciences) ·(unknown), (unknown), Kimie Imai, Katsuya Suemaru, Hiroaki Araki, Tachio Aimoto	12
6	Evaluation of Experience-oriented Hospital Practical Training for Fourth-year Undergraduate Students 2006 ·Iryo Yakugaku (Japanese Journal of Pharmaceutical Health Care and Sciences) ·Katsuya Suemaru, (unknown), (unknown), Takumi Yamaguchi, (unknown), (unknown), (unknown), (unknown), Mamoru Tanaka, (unknown), (unknown), (unknown), Hiroaki Araki	16
7	Practical Training in Use of Bronchial Asthma Inhalers for Fifth-year Medical and Fourth-year Pharmacy Students 2004 ·Iryo Yakugaku (Japanese Journal of Pharmaceutical Health Care and Sciences) ·Katsuya Suemaru, (unknown), Hiroaki Araki	6
8	Introduction of PBL into Clinical Pharmacy Education-Participation of Hospital Pharmacists and Evaluation by the Students- 2004 ·Iryo Yakugaku (Japanese Journal of Pharmaceutical Health Care and Sciences) ·(unknown), (unknown), (unknown), Yuji Kurosaki, Hiroaki Araki, Yutaka Gomita	13
9	Modulation of 8-OH-DPAT-Induced Hypothermia by Imipramine in Rats 2003 ·SHILAP Revista de lepidopterología ·Yoshihisa Kitamura, Hiroaki Araki, Kazuhiko Shibata, Yutaka Gomita, (unknown)	0
10	The Features Regarding the Absorption of Tacrolimus by PVC and PB Tubes and Effects of Such Absorption of Tacrolimus on the Blood Concentration and Dosage in Patients 2003 ·Iryo Yakugaku (Japanese Journal of Pharmaceutical Health Care and Sciences) ·(unknown), Yoshihisa Kitamura, (unknown), Noriko Yokoyama, Hiroaki Araki, Yutaka Gomita	0
11	Cessation of repeated administration of MK-801 changes the anticonvulsant effect against flurothyl-induced seizure in mice 2003 ·Pharmacology Biochemistry and Behavior ·Yasuhiko Hashimoto, Hiroaki Araki, Yutaka Gomita	4
12	Pharmacist's Roles in Investigator-initiated Clinical Researches at Okayama University Hospital. 2002 ·Iryo Yakugaku (Japanese Journal of Pharmaceutical Health Care and Sciences) ·Koujiro Futagami, (unknown), Shigeki Nishihara, (unknown), Hiroaki Araki, Yutaka Gomita	0
13	Introduction of an Audit System to Maintain and Improve Quality in both Pharmaceutical Management and Counseling Services. 2002 ·Iryo Yakugaku (Japanese Journal of Pharmaceutical Health Care and Sciences) ·(unknown), Koujiro Futagami, Masatoshi Okazaki, (unknown), Hiroaki Araki, Yutaka Gomita	1
14	Evaluation of the Reviewing Procedure Prior to the Institutional Review Board Meeting for Clinical Trials in Okayama University Medical School Hospital. 2001 ·Rinsho yakuri/Japanese Journal of Clinical Pharmacology and Therapeutics ·Koujiro Futagami, Hiroaki Araki, (unknown), Yutaka Gomita	1
15	The Effect of the Mixed Witepsol Base on the Drug Release from the Zonisamide Suppository. 2000 ·Japanese Journal of Hospital Pharmacy ·(unknown), (unknown), (unknown), Katsuya Suemaru, (unknown), Kazuhide Watanabe, Hiroaki Araki, Yutaka Gomita	2
16	Clinical Use of Drug Delivery Systems: Prescription Survey on Clinical Use of PGE1 in Lipid Emulsions with Aqueous Infusions. 1999 ·Japanese Journal of Hospital Pharmacy ·(unknown), Yuji Kurosaki, Keita Yamauchi, (unknown), Hiroaki Araki, Yutaka Gomita, Nobuyuki Goto, Mikio Masada, Hiromu Kawasaki	1
17	Effect of lipo-PGI2 analogue TTC-909 on cerebral glucose metabolism during the recovery period following focal cerebral ischemia. 1994 ·Nosotchu ·Katsuji Shima, (unknown), H Chigasaki, Shigeru Okuyama, Hiroaki Araki	0
18	Repeated dose toxicity study of intravenous treatment with taurine for 13 weeks and recovery test for 5 weeks in rat 1991 ·Shigenori Furukawa, (unknown), (unknown), (unknown), (unknown), Y. Taniguchi, Takashi Toda, Hiroaki Araki	9
19	5-HT3 receptor antagonists inhibit the response of κ oploid receptors in the morphine-reduced straub tail 1990 ·European Journal of Pharmacology ·Yutaka Hasegawa, Michio Kurachi, Shigeru Okuyama, Hiroaki Araki, Susumu Otomo	17
20	Behavioral and EEG effects of triazolam in comparison with those of diazepam 1978 ·Folia Pharmacologica Japonica ·Showa Ueki, Shigenori Watanabe, Michihiro Fujiwara, Tsuneyuki Yamamoto, Hiroaki Araki, Kenji Ohmori	3

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact